Anti-Proliferative Effects of Evodiamine on Human Breast Cancer Cells.
Endocrine sensitivity, assessed by the expression of estrogen receptor (ER), has long been the predict factor to guide therapeutic decisions. Tamoxifen has been the most successful hormonal treatment in endocrine-sensitive breast cancer. However, in estrogen-insensitive cancer tamoxifen showed less...
Main Authors: | Kai-Lee Wang, Shih-Min Hsia, Jiun-Yih Yeh, Shao-Chi Cheng, Paulus S Wang, Shyi-Wu Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3694052?pdf=render |
Similar Items
-
Anti-Proliferative Effects of Evodiamine on Human Breast Cancer Cells
by: Shao-Chi Cheng, et al.
Published: (2005) -
Anti-Proliferative Effects of Evodiamine on Human Thyroid Cancer Cell Line ARO
by: Meng-Ching Chen, et al.
Published: (2007) -
The Anti-Cancer Mechanism of Evodiamine, Genistein and YC-1 in Human Breast Cancer Cell Lines
by: Cho-Hwa Liao, et al.
Published: (2005) -
Evodiamine synergizes with doxorubicin in the treatment of chemoresistant human breast cancer without inhibiting P-glycoprotein.
by: Shengpeng Wang, et al.
Published: (2014-01-01) -
Traditional Chinese medicine for anti-Alzheimer’s disease: berberine and evodiamine from Evodia rutaecarpa
by: Zhiling Fang, et al.
Published: (2020-08-01)